Clinically relevant postoperative pancreatic fistula (CR-POPF) after pancreaticoduodenectomy in treatment periampullary cancer: morphology and risk factors: A multicenter prospective study

Clinically relevant postoperative pancreatic fistula (CR-POPF) after pancreaticoduodenectomy in treatment periampullary cancer - CR-POPF after PD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045476

Enrollment

150

Registered

2021-09-15

Start date

2021-08-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periampullary cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with periampullary cancer and: - Postoperative pathology is carcinoma of pancreas, duodenum, biliary duct, ampulla Vater. - Possibility of pancreaticoduodenectomy

Exclusion criteria

Exclusion criteria: The patients who do not agree to participate in the study

Design outcomes

Primary

Measure	Time frame
Postoperative pancreatic fistula (POPF) Time: we will measure abdominal fluid's amylase on postoperative day 3rd to determine whether there is POPF. We follow within 90 days after pancreaticoduodenectomy	—

Secondary

Measure	Time frame
Risk factors relating to postoperative pancreatic fistula	—

Countries

Asia(except Japan)

Contacts

Public ContactVo Quoc

University of Medicine and Pharmacy at Ho Chi Minh City UMP

bsvotruongquoc@ump.edu.vn084364662378

Outcome results